Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
2017 · JAMA · 2,455 citations
https://doi.org/10.1001/jama.2017.18718
F
Frank S. Lieberman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
339
Papers
12.4K
Citations
48
h-index
105
i10-index
Frank S. Lieberman is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 48, co-authored 289 publications.
ORCID: 0000-0003-2577-3336Papers by this author
worksAutologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
2007 · Journal of Translational Medicine · 128 citations
https://doi.org/10.1186/1479-5876-5-67
Neuro-oncology family caregivers’ view on keeping track of care issues using eHealth systems: it’s a question of time
2017 · Journal of Neuro-Oncology · 28 citations
https://doi.org/10.1007/s11060-017-2504-y
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
2025 · Science Translational Medicine · 10 citations
https://doi.org/10.1126/scitranslmed.adn6274
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
2025 · Neuro-Oncology · 4 citations
https://doi.org/10.1093/neuonc/noaf079
Fast Hadamard-Encoded 7T Spectroscopic Imaging of Human Brain
2025 · Tomography · 0 citations
https://doi.org/10.3390/tomography11010007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat